Regeneron stock edged higher Thursday despite mixed results for its bread-and-butter eye-disease treatment franchise, Eylea. ↑ X NOW PLAYING How To Buy Stocks: Cup With Handle...
Medical aesthetics company Evolus (EOLS) notched its first-ever profit late Wednesday, two quarters ahead of expectations. ↑ X NOW PLAYING Biotech Stocks Are Shooting Higher. Here’s...
Nurix Therapeutics (NRIX) posted a “clear win” in leukemia treatment on Monday, but the biotech stock reversed lower at the open, giving up a potential breakout....
The stock market rallied for the week, with Friday’s weaker-than-expected jobs report bolstering a relatively dovish Federal Reserve and Fed chief Jerome Powell on Wednesday. The...